[
    {
      "doi": "10.1016/S2213-2600(23)00083-8",
      "authors": [
        {
          "name": "Jonathan S Nguyen-Van-Tam",
          "institution": [],
          "funders": [
            {
              "name": "Department of Health and Social Care, England"
            },
            {
              "name": "Gilead"
            },
            {
              "name": "F Hoffmann-La Roche"
            }
          ]
        },
        {
          "name": "Kerenza Hood",
          "institution": [],
          "funders": [
            {
              "name": "UK National Institute for Health and Care Research (NIHR)"
            },
            {
              "name": "AstraZeneca"
            },
            {
              "name": "OCTAVE-DUO trial"
            }
          ]
        },
        {
          "name": "David M Lowe",
          "institution": [],
          "funders": [
            {
              "name": "LifeArc"
            },
            {
              "name": "UK Medical Research Council"
            },
            {
              "name": "Bristol Myers Squibb"
            },
            {
              "name": "GlaxoSmithKline"
            },
            {
              "name": "British Society for Antimicrobial Chemotherapy"
            },
            {
              "name": "Blood Cancer UK"
            },
            {
              "name": "Biotest UK"
            },
            {
              "name": "Gilead"
            },
            {
              "name": "Merck"
            },
            {
              "name": "Octapharma"
            }
          ]
        },
        {
          "name": "Duncan B Richards",
          "institution": [],
          "funders": [
            {
              "name": "OMASS Therapeutics"
            },
            {
              "name": "Heal-COVID trial TMG"
            }
          ]
        },
        {
          "name": "Benjamin R Saville",
          "institution": [
            {
              "name": "University of Oxford"
            }
          ],
          "funders": [
            {
              "name": "Berry Consultants"
            }
          ]
        },
        {
          "name": "Joe Marion",
          "institution": [
            {
              "name": "University of Oxford"
            }
          ],
          "funders": [
            {
              "name": "Berry Consultants"
            }
          ]
        },
        {
          "name": "Michelle A Detry",
          "institution": [
            {
              "name": "University of Oxford"
            }
          ],
          "funders": []
        },
        {
          "name": "Christina T Saunders",
          "institution": [
            {
              "name": "University of Oxford"
            }
          ],
          "funders": []
        },
        {
          "name": "Nicholas S Berry",
          "institution": [
            {
              "name": "University of Oxford"
            }
          ],
          "funders": []
        },
        {
          "name": "Mark Fitzgerald",
          "institution": [
            {
              "name": "University of Oxford"
            }
          ],
          "funders": []
        },
        {
          "name": "Mark Lown",
          "institution": [],
          "funders": [
            {
              "name": "RAPIS-TEST"
            },
            {
              "name": "NIHR efficacy and mechanism evaluation"
            }
          ]
        },
        {
          "name": "Saye Khoo",
          "institution": [],
          "funders": [
            {
              "name": "GlaxoSmithKline"
            },
            {
              "name": "ViiV"
            },
            {
              "name": "Ridgeback Biotherapeutics"
            },
            {
              "name": "Vir"
            },
            {
              "name": "Merck"
            },
            {
              "name": "UK Medical Research Council"
            },
            {
              "name": "Wellcome Trust"
            },
            {
              "name": "ViiV Healthcare"
            },
            {
              "name": "Toyama"
            }
          ]
        },
        {
          "name": "Joseph F Standing",
          "institution": [],
          "funders": [
            {
              "name": "GlaxoSmithKline"
            },
            {
              "name": "UK Medical Research Council"
            },
            {
              "name": "Wellcome Trust"
            },
            {
              "name": "NIHR"
            },
            {
              "name": "Drugs for Neglected Diseases Initiative"
            }
          ]
        },
        {
          "name": "Monique Andersson",
          "institution": [],
          "funders": [
            {
              "name": "Blood and Transplant Research Unit"
            },
            {
              "name": "Janssen"
            },
            {
              "name": "Pfizer"
            },
            {
              "name": "Prenetics"
            },
            {
              "name": "Dunhill Medical Trust"
            },
            {
              "name": "BMA Trust (Kathleen Harper Fund)"
            },
            {
              "name": "Antibiotic Research UK"
            },
            {
              "name": "OxDx"
            },
            {
              "name": "E3 Initiative"
            }
          ]
        },
        {
          "name": "Nicholas P B Thomas",
          "institution": [],
          "funders": [
            {
              "name": "MSD"
            }
          ]
        },
        {
          "name": "Oliver van Hecke",
          "institution": [
            {
              "name": "Oxford University lnnovation"
            }
          ],
          "funders": [
            {
              "name": "MindGap"
            },
            {
              "name": "CHICO trial"
            },
            {
              "name": "British Society of Antimicrobial Chemotherapy"
            }
          ]
        },
        {
          "name": "Andrew Ustianowski",
          "institution": [],
          "funders": [
            {
              "name": "MSD"
            },
            {
              "name": "GlaxoSmithKline"
            },
            {
              "name": "Gilead"
            }
          ]
        },
        {
          "name": "Nick Francis",
          "institution": [],
          "funders": [
            {
              "name": "Abbott Diagnostics"
            },
            {
              "name": "GlaxoSmithKline"
            },
            {
              "name": "PRINCIPLE trial data safety monitoring board"
            },
            {
              "name": "NIHR Health Technology Assessment General Funding Committee"
            },
            {
              "name": "Synairgen"
            }
          ]
        },
        {
          "name": "Judith Breuer",
          "institution": [],
          "funders": [
            {
              "name": "GlaxoSmithKline"
            }
          ]
        }
      ],
      "funders": [
        {
          "name": "NIHR"
        },
        {
          "name": "NIHR Community Healthcare Medtech and In-Vitro Diagnostics Co-operative"
        },
        {
          "name": "NIHR Health Protection Research Unit on Health Care Associated Infections and Antimicrobial Resistance"
        },
        {
          "name": "NIHR Applied Research Collaboration"
        },
        {
          "name": "Wellcome Trust PhD programme for primary care clinicians"
        },
        {
          "name": "European Clinical Research Alliance on Infectious Diseases"
        },
        {
          "name": "University College London Hospitals NIHR Biomedical Research Centre"
        },
        {
          "name": "Health and Care Research Wales"
        },
        {
          "name": "Cardiff University"
        }
      ]
    }
  ]